课题基金 / 基金详情

14th Biennial Congress of the Anaerobes Society of the Americas

14th Biennial Congress of the Anaerobes Society of the Americas
第 14 届美洲厌氧菌协会双年度大会
批准号:
9543728
负责人:
JEANNE M MARRAZZO
金额:
$0.6万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-06-28 至 2019-05-31

项目摘要

项目成果

JEANNE M MARRAZZO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary Anaerobes, bacteria that thrive in the absence of oxygen, are both major contributors to disease as well as critical to human health. While Clostridium difficile is a serious infectious disease threat and a leading cause of healthcare-associated infections, we are increasingly aware that anaerobes contribute in a beneficial way to the structure and function of the human microbiome. Although regional Societies focused on anaerobe bacterial science exist in select locales abroad (e.g., Britain, Japan), the Anaerobe Society of the Americas (ASA) is the only United States-based Society devoted to the basic and clinical science of anaerobes. Further, the ASA has long had an active international membership with representation from more than 30 countries at the 2016 Biennial Congress. The long-term goal of the ASA and its biennial congress (founded in 1992) is to promote health and advance science through the study of anaerobic bacteria and their environments. This proposal seeks NIH support for ANAEROBE 2018, the 14th Biennial Congress of the ASA, which will be hosted from July 9-12, 2018 in Las Vegas, NV. The specific aims of the 14th Biennial Congress are: (1) to stimulate interest in anaerobes and to encourage and facilitate interchange among anaerobists from all disciplines, including medical, dental, veterinary, microbiology and basic sciences fields of study; (2) to assess our current understanding of the microbiota and its contribution to health disease; (3) to discuss controversies and advances in disease induction by Clostridium species and grapple with the increasing problem of antimicrobial resistance in C. difficile, Bacteroides species, and other anaerobic bacteria; and (4) to probe emerging mechanisms of action, health benefits, and regulatory issues in probiotic development and clinical use of microbiota transfer. The 14th Biennial Congress will accomplish this goal through presentations by more than 20 domestic and international expert scientific speakers and a variety of presentation formats. The Organizing Committee has created a program that fosters diversity among the participants and attendees at ANAEROBE 2018. The one-room, intimate nature of the conference will encourage a hearty, person-to-person, interdisciplinary exchange between scientists who do not generally meet together in any other conference venue. Consistent with the goals of the NIH and NIAID, the 14th Biennial Congress of the ASA provides a unique opportunity to bring together the world’s leading basic and clinical investigators in anaerobe bacterial science and its translation toadvance studies with lasting impact on human health.!
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sexually Transmitted Infections Clinical Trials Group: Phase 2 Clinical Trial to Evaluate a Vaccine Candidate for Neisseria Gonorrhoeae
Sexually Transmitted Infections Clinical Trials Group
Sexually Transmitted Infections Clinical Trials Group: Phase 2 Clinical Trial to Evaluate a Vaccine Candidate for Neisseria Gonorrhoeae
Sexually Transmitted Infections Clinical Trials Group
海外基金